Zhifei Biotech: Announcement on the Continued Inclusion of Recombinant Mycobacterium Tuberculosis Fusion Protein (EC) in the National Medical Insurance Catalogue

SZSI · Nov 28, 2024 16:56

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.